The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases

Molecular and Cellular Biology

Volumn 21, Issue 7, 2001, Pages 2259-2268

  Wu, W S ^a   Vallian, S ^a   Seto, E ^a   Yang, W M ^a   Edmondson, D ^a   Roth, S ^a   Chang, K S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; HYBRID PROTEIN; TRICHOSTATIN A;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL CYCLE; CHROMOSOME TRANSLOCATION 15; ENZYME ACTIVITY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ANIMALS; COS CELLS; HISTONE DEACETYLASES; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN BINDING; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS; ZINC FINGERS;

EID: 0035099686     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.7.2259-2268.2001     Document Type: Article

References (77)

1. The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter
2. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells
3. Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML
4. The promyetocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein
5. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3
6. The CBP co-activator is a histone acetyltransferase
7. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia
8. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17
9. Transcriptional silencing in yeast is associated with reduced nucleosome acetylation
10. Retinoblastoma protein recruits histone deacetylase to repress transcription
11. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia
12. HDA1 and HDA3 are components of a yeast histone deacetylase (HDA) complex
13. Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML
14. The PML gene encodes a phosphoprotein associated with the nuclear matrix
15. Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia
16. 3 exerts dose-dependent dual effects on APL cells
17. The PML-RARalpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
18. Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-1 Tax oncoprotein
19. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure
20. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
21. Characterization of a human RPD3 ortholog, HDAC3
22. HSV-1 IE protein Vmw110 causes redistribution of PML
23. Molecular cloning of a new interferon-induced PML nuclear body-associated protein
24. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia
25. The acute promyelocytic leukemia-specific PML-RARalpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells
26. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells
27. Altered myeloid development and acute leukemia in transgenic mice expressing PMLRARa under control of cathepsin G regulatory sequences
28. Mistone acetylation in chromatin structure and transcription
29. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors
30. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression
31. Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells
32. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL
33. Acute leukemia with promyelocytic features in PMLRARalpha transgenic mice
34. Chromosomal translocation t(15:17) in human acute promyelocytic leukemia fuses RARalpha with a novel putative transcription factor, PML
35. Identification of three major sentrinization sites in PML
36. Covalent modification of PML by the sentrin family of ubiquitin-like proteins
37. Interaction of Sp1 with the growth-and cell cycle-regulated transcription factor E2F
38. Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies
39. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression
40. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body
41. 1 cell cycle arrest and apoptosis
42. Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML
43. A positive role for histone acetylation in transcription factor access to nucleosomal DNA
44. Sequestration and inhibition of Daxx-mediated transcription repression by PML
45. Role of the histone deacetylase complex in acute promyelocytic leukemia
46. Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction
47. PML suppresses oncogenic transformation of N1H/3T3 cells by activated neu
48. Rb interacts with histone deacetylase to repress transcription
49. Retinoblastoma protein represses transcription by recruiting a histone deacetylase
50. The TAF(11)250 subunit of TF11D has histone acetyltransferase activity
51. PML, a growth suppressor disrupted in acute promyelocytic leukemia
52. Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells
53. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus
54. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase
55. The transcriptional coactivators p300 and CBP are histone acetyltransferases
56. What's up and down with histone deacetylation and transcription?
57. PMLRAR homodimers: Distinct DNA binding properties and heteromeric interactions with RXR
58. PML induces a novel caspase-independent death process
59. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells
60. 3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients
61. G1 phase progression: Cycling on cue
62. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1
63. Histone acetylation and transcriptional regulatory mechanisms
64. The epstein-barr virus-encoded nuclear antigen ebna-5 accumulates in PML-containing bodies
65. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
66. Regulation of Fos-mediated AP1 transcription by the promyelocytic leukemia protein
67. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter
68. Transcriptional repression by the promyelocytic leukemia protein, PML
69. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro
70. Histone acetyltransferases in control
71. Role of PML in cell growth and the retinoic acid pathway
72. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner
73. PML is essential for multiple apoptotic pathways
74. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)
75. Retinoic acid regulates aberrant nuclear localization of PML-RARalpha in acute promyelocytic leukemia cells
76. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family
77. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: Possible role of the proteasome pathway